AHG - CIK 0001702318
Akso Health Group trades as AHG and has a market capitalization of $2.29 B, making it the #2002 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $14.78M, up 512.1% from the prior year and net income of -$134.98M. This page tracks Akso Health Group through 194 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 8 fiscal years Akso Health Group's revenue declined from $22.92M to $14.78M, a compound annual decline rate of 5.3%. Net profit margin compressed from 37.4% to -913.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-13 |
| New insider ownership | 3 | 2026-04-06 |
| New insider ownership | 3 | 2026-03-30 |
| New insider ownership | 3 | 2026-03-27 |
| 6-K | - | 2026-03-23 |
| New insider ownership | 3 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 |
The largest companies sharing Akso Health Group's SEC industry classification (services-business services, nec).
Akso Health Group (AHG) has a market capitalization of $2.29 B as of 2026-06-10, ranking #2002 among US-listed companies.
Akso Health Group reported revenue of $14.78M for fiscal year 2025, an increase of 512.1% year over year.
In its latest fiscal year Akso Health Group reported a net loss of $134.98M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.